Growth Metrics

Thermo Fisher Scientific (TMO) Short term Debt (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Short term Debt readings, the most recent being $3.1 billion for Q1 2026.

  • On a quarterly basis, Short term Debt rose 9.61% to $3.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.1 billion, a 9.61% increase, with the full-year FY2025 number at $3.5 billion, up 59.58% from a year prior.
  • Short term Debt hit $3.1 billion in Q1 2026 for Thermo Fisher Scientific, down from $3.5 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.1 billion in Q2 2023 to a low of $1.0 billion in Q3 2022.
  • Median Short term Debt over the past 5 years was $3.6 billion (2023), compared with a mean of $3.5 billion.
  • Biggest five-year swings in Short term Debt: soared 46550.0% in 2022 and later plummeted 56.77% in 2025.
  • Thermo Fisher Scientific's Short term Debt stood at $5.6 billion in 2022, then plummeted by 35.31% to $3.6 billion in 2023, then tumbled by 38.65% to $2.2 billion in 2024, then surged by 59.58% to $3.5 billion in 2025, then dropped by 12.54% to $3.1 billion in 2026.
  • The last three reported values for Short term Debt were $3.1 billion (Q1 2026), $3.5 billion (Q4 2025), and $3.8 billion (Q3 2025) per Business Quant data.